Analysis of G:C>T:A, G:C>A:T, and G:C>C:G Mutations in the TP53 Gene in Women with and without Breast Cancer in the Long-Term Period after Chronic Radiation Exposure

The results of analysis of mutations such as G:C>T:A, G:C>A:T, and G:C>C:G in the TP53 gene in peripheral blood cells in women affected by chronic radiation exposure with breast cancer (24 women) and without breast cancer (17 women) are presented. Seventeen different variants representing single nucleotide substitutions were registered. The differences in the frequencies of carriers of the detected variants between the comparison and the main group were not statistically significant. All detected variants were present in the IARC TP53 database and had no clinical significance as “pathogenic.” Despite the absence of statistically significant differences, the question of the effect of chronic low dose rate exposure on the frequency of mutations in the TP53 gene remains open and requires further research involving a greater quantity of data.

Authors

Institutions

Publication Details

Journal
Biology Bulletin
Published
2024-11-08
DOI
https://doi.org/10.1134/s1062359024610267
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of G:C>T:A, G:C>A:T, and G:C>C:G Mutations in the TP53 Gene in Women with and without Breast Cancer in the Long-Term Period after Chronic Radiation Exposure

А. V. Akleyev, А. V. Korechenkova, В. С. Никифоров
Biology Bulletin
Cancer-related Molecular Pathways
article

Analysis of G:C>T:A, G:C>A:T, and G:C>C:G Mutations in the TP53 Gene in Women with and without Breast Cancer in the Long-Term Period after Chronic Radiation Exposure

А. V. Akleyev, А. V. Korechenkova, В. С. Никифоров
article en

Abstract

The results of analysis of mutations such as G:C>T:A, G:C>A:T, and G:C>C:G in the TP53 gene in peripheral blood cells in women affected by chronic radiation exposure with breast cancer (24 women) and without breast cancer (17 women) are presented. Seventeen different variants representing single nucleotide substitutions were registered. The differences in the frequencies of carriers of the detected variants between the comparison and the main group were not statistically significant. All detected variants were present in the IARC TP53 database and had no clinical significance as “pathogenic.” Despite the absence of statistically significant differences, the question of the effect of chronic low dose rate exposure on the frequency of mutations in the TP53 gene remains open and requires further research involving a greater quantity of data.

Biology BulletinVol. 51(6)
Chelyabinsk State University (RU), Urals Research Center for Radiation Medicine (RU), Federal Medical-Biological Agency (RU)
Good health and well-being
Openalex Percentile: Top 64%
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.